National Research Corporation
NASDAQ:NRCMedical - Healthcare Information Services
+$0.07 today
- Market cap
- $555.16M
- Beta
- 0.40
- P/E (TTM)
- 43.0
- EPS (TTM)
- $0.41
- Dividend yield
- 3.14%
Volume 0.09M
Average 0.11M
NRC Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
National Research CorporationNASDAQ: NRC
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity falls 54.5% from a year ago
Total equity stood at $13.5M at the end of Q1 FY2026, down 54.5% from a year earlier and down 3.5% from the prior quarter. Over 3 fiscal years it compounded at -42.1% a year.
Context
- Total equity amounted to 10.0% of total assets at the end of Q1 FY2026, down 11.9 pp from a year earlier.
- Total equity increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -54.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 13.99M USD
- Year-over-year change
- -55.3%
- 4-year CAGR
- -36.4%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.99M | -55.3% |
| FY2024 | 2024-12-31 | 31.28M | -36.1% |
| FY2023 | 2023-12-31 | 48.96M | -32.0% |
| FY2022 | 2022-12-31 | 72.03M | -15.6% |
| FY2021 | 2021-12-31 | 85.34M | — |
Total Equity vs competitors
How NRC compares with its peers on the latest reported figures
- NRC's Mar 2026 total equity of $13.5M is the 7th highest of the 8 companies compared; the peer median is $138.15M.
- Its year-over-year change of -54.5% is the 5th highest of 8, against a peer median of -46.6%.
- Total equity amounts to 10.0% of total assets for NRC, versus a peer median of 37.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Apr 2026 | $359.09M | +27.3% | +5.4% | 53.9% | |
| Mar 2026 | $351.99M | -3.0% | +2.0% | 66.7% | |
| Mar 2026 | $190.7M | -56.3% | -36.5% | 37.0% | |
| Mar 2026 | $138.15M | -63.3% | -16.7% | 33.5% | |
| Mar 2026 | $58.33M | +7.7% | -16.4% | 67.3% | |
| Mar 2026 | $45.69M | -46.6% | -38.2% | 29.1% | |
| Mar 2026 | $13.5M | -54.5% | -42.1% | 10.0% | |
CTEVClaritev Corporation | Mar 2026 | -$234.41M | -1681.2% | — | 4.8% |
| Peer median (excluding NRC) | $138.15M | -46.6% | -16.5% | 37.0% | |
Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 54.36M | 25.03M | 6.65M | 4.23M | 4.14M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 14.58M | 15.3M | 12.62M | 11.2M | 11.64M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 883K | 1.01M | 856K | 692K | 520K |
| Total Current Assets | 73.71M | 43.72M | 24.36M | 19.6M | 20.21M |
| Property, Plant & Equipment (Net) | 13.37M | 17.8M | 30.27M | 39.9M | 40.47M |
| Goodwill | 61.61M | 61.61M | 61.61M | 66.15M | 66.15M |
| Intangible Assets | 1.79M | 1.61M | 1.47M | 2.62M | 2.23M |
| Long-term Investments | 0 | 0 | 0 | 1.3M | 0 |
| Tax Assets | 14K | 14K | 0 | 0 | 0 |
| Other Non-current Assets | 7.05M | 5.7M | 4.73M | 2.98M | 5.82M |
| Total Non-current Assets | 83.83M | 86.75M | 98.08M | 112.94M | 114.67M |
| Total Assets | 157.54M | 130.46M | 122.44M | 132.54M | 134.88M |
| Account Payables | 1.94M | 1.15M | 1.3M | 1.19M | 4.07M |
| Short-term Debt | 5.24M | 5.32M | 7.82M | 4.79M | 4.01M |
| Tax Payables | 0 | 0 | 222K | 353K | 0 |
| Deferred Revenue | 17.21M | 15.2M | 14.83M | 15.79M | 16.2M |
| Other Current Liabilities | 8.85M | 7.19M | 8.08M | 541K | 5.12M |
| Total Current Liabilities | 40.39M | 33.42M | 36.2M | 35.86M | 36.62M |
| Long-term Debt | 22.27M | 17.69M | 29.47M | 57.9M | 75.02M |
| Deferred Tax Liabilities | 7M | 5.27M | 4.14M | 3.53M | 5.98M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 216K | 0 |
| Other Non-current Liabilities | 1.38M | 1.67M | 2M | 2.59M | 3.26M |
| Total Non-current Liabilities | 31.82M | 25.01M | 37.28M | 65.4M | 84.27M |
| Total Liabilities | 72.2M | 58.43M | 73.48M | 101.26M | 120.89M |
| Common Stock | 31K | 31K | 31K | 31K | 32K |
| Retained Earnings | (36.11M) | (25.18M) | (30.53M) | (17.06M) | (17.3M) |
| Accumulated OCI | (2.38M) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 85.34M | 72.03M | 48.96M | 31.28M | 13.99M |
| Total Debt | 28.68M | 23.39M | 38.96M | 64.41M | 79.04M |
| Net Debt | (25.68M) | (1.64M) | 32.3M | 60.18M | 74.9M |
National Research Corporation
NASDAQ:NRC
Intrinsic Alpha fair value
Locked
Current Price
$26.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.